UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A bistable Rb-E2F switch underlies the restriction point

Nature cell biology, 2008-04, Vol.10 (4), p.476-482

2008

Volltextzugriff (PDF)

High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics

Journal of the American Statistical Association, 2008-12, Vol.103 (484), p.1438-1456

2008

Volltextzugriff (PDF)

Mining gene expression profiles: expression signatures as cancer phenotypes

Nature reviews. Genetics, 2007-08, Vol.8 (8), p.601-609

2007

Volltextzugriff (PDF)

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3324-3330

2008

Volltextzugriff (PDF)

pathway-based classification of human breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (15), p.6994-6999

2010

Volltextzugriff (PDF)

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Nature, 2006-01, Vol.439 (7074), p.353-357

2006

Volltextzugriff (PDF)

Origin of bistability underlying mammalian cell cycle entry

Molecular systems biology, 2011, Vol.7 (1), p.485-n/a

2011

Volltextzugriff (PDF)

Balancing the decision of cell proliferation and cell fate

Cell cycle (Georgetown, Tex.), 2009-02, Vol.8 (4), p.532-535

2009

Volltextzugriff (PDF)

Genomic signatures to guide the use of chemotherapeutics

Nature medicine, 2006-11, Vol.12 (11), p.1294-1300

2006

Volltextzugriff (PDF)

FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (19), p.6056-6067

2013

Volltextzugriff (PDF)

Using a Stem Cell―Based Signature to Guide Therapeutic Selection in Cancer

Cancer research (Chicago, Ill.), 2011-03, Vol.71 (5), p.1772-1780

2011

Volltextzugriff (PDF)

Network calisthenics: Control of E2F dynamics in cell cycle entry

Cell cycle (Georgetown, Tex.), 2011-09, Vol.10 (18), p.3086-3094

2011

Volltextzugriff (PDF)

Gene expression signatures of radiation response are specific, durable and accurate in mice and humans

PloS one, 2008-04, Vol.3 (4), p.e1912

2008

Volltextzugriff (PDF)

Gene expression signatures that predict radiation exposure in mice and humans

PLoS medicine, 2007-04, Vol.4 (4), p.e106

2007

Volltextzugriff (PDF)

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2198-2206

2010

Volltextzugriff (PDF)

An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer

Journal of clinical oncology, 2007-02, Vol.25 (5), p.517-525

2007

Volltextzugriff (PDF)

Stochastic E2F activation and reconciliation of phenomenological cell-cycle models

PLoS biology, 2010-09, Vol.8 (9), p.e1000488

2010

Volltextzugriff (PDF)

Gene expression profiling and genetic markers in glioblastoma survival

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4051-4058

2005

Volltextzugriff (PDF)

SIGNATURE: a workbench for gene expression signature analysis

BMC bioinformatics, 2011-11, Vol.12 (1), p.443-443, Article 443

2011

Volltextzugriff (PDF)

Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

Clinical cancer research, 2005-05, Vol.11 (10), p.3686-3696

2005

Volltextzugriff (PDF)

Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma

Clinical cancer research, 2009-01, Vol.15 (2), p.502-510

2009

Volltextzugriff (PDF)

Author Correction: Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control

Nature communications, 2018-11, Vol.9 (1), p.4766-1, Article 4766

2018

Volltextzugriff (PDF)

The E2F1-3 transcription factors are essential for cellular proliferation

Nature (London), 2001-11, Vol.414 (6862), p.457-462

2001

Volltextzugriff (PDF)

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential

Proceedings of the National Academy of Sciences - PNAS, 2009-09, Vol.106 (38), p.16387-16392

2009

Volltextzugriff (PDF)

E2F: A Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins

Science (American Association for the Advancement of Science), 1992-10, Vol.258 (5081), p.424-429

Nevins, Joseph R.

1992

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(290)

Publikationsform

Sprache

Englisch
(319)
Japanisch
(63)
Paschtu
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(201)
Life Sciences & Biomedicine
(152)
Humans
(140)
Animals
(95)
Biological And Medical Sciences
(83)
Cell Biology
(70)
Biochemistry & Molecular Biology
(63)
Fundamental And Applied Biological Sciences. Psychology
(57)
E2f Transcription Factors
(51)
Female
(51)
Transcription Factors - Metabolism
(50)
Mice
(48)
Transcription, Genetic
(47)
Gene Expression Regulation
(46)
Gene Expression
(45)
Gene Expression Profiling
(44)
Multidisciplinary Sciences
(44)
Science & Technology - Other Topics
(44)
Transcription Factors - Genetics
(44)
Base Sequence
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A bistable Rb-E2F switch underlies the restriction point

High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics

Mining gene expression profiles: expression signatures as cancer phenotypes

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

pathway-based classification of human breast cancer

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Origin of bistability underlying mammalian cell cycle entry

Balancing the decision of cell proliferation and cell fate

Genomic signatures to guide the use of chemotherapeutics

FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function

Using a Stem Cell―Based Signature to Guide Therapeutic Selection in Cancer

Network calisthenics: Control of E2F dynamics in cell cycle entry

Gene expression signatures of radiation response are specific, durable and accurate in mice and humans

Gene expression signatures that predict radiation exposure in mice and humans

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer

Stochastic E2F activation and reconciliation of phenomenological cell-cycle models

Gene expression profiling and genetic markers in glioblastoma survival

SIGNATURE: a workbench for gene expression signature analysis

Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma

Author Correction: Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control

The E2F1-3 transcription factors are essential for cellular proliferation

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential

E2F: A Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins

Suchergebnisse filtern